3458 results for «30MDL多少人民币»
3458 results
30 years of Rotary ablation
18 May 2021 – From EuroPCR 2021
Watch this session presented by Maurice Buchbinder to learn all about the history of rotary ablation, from its invention 30 years ago to its current practice, and discover various cases highlighting the results of this therapy.
30 years of primary PCI – a tale of perseverance
16 May 2023
Over the last 30 years, primary PCI (pPCI) has evolved from an experimental ‘rescue’ intervention to an essential routine procedure – performed daily in cathlabs around the world – which is responsible for saving millions of lives. However, its path to success was far from smooth.
Celebrating 30 years of transradial artery access!
17 May 2022
Thirty years ago, the interventional cardiology field was transformed with the emergence of a new access site – the radial artery was used for coronary angioplasty and stent implantation for the first time on 14 August 1992.
Author
Author
30-day outcomes following transfemoral transseptal transcatheter mitral valve replacement: Intrepid TMVR early feasibility study results
21 Jan 2022
The study by Zahr et al. reports the results of an interim analysis assessing procedural and clinical outcomes at 30-day in 15 patients treated with the newly developed Medtronic Intrepid 35-F trans-femoral transcatheter mitral valve replacement (TMVR) system.
Reviewer
The history of EuroPCR - 30 years of innovation in education
04 Apr 2019
Discover the story and illustrations of the Course that has grown from a few dozen participants in 1989 to over 11,000!
SASCI-AfricaPCR - 29-30 January 2027
29-30 January 2027
Cape Town , South Africa
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
A dedicated TAVI valve for aortic regurgitation: the J-VALVE solution
26 Nov 2024 – From PCR London Valves 2024
Discover the 30-day outcomes of the novel transfemoral J-VALVE solution, a dedicated TAVI device designed specifically for the treatment of aortic regurgitation. Understand its unique automatic anchoring mechanism and the remarkable left ventricular remodelling it can facilitate.
Complex non left main bifurcation PCI - LIVE case
19 Dec 2024 – From GulfPCR-GIM 2024
A 71-year-old male presented with angina (CCS 2), normal left ventricular function, and mitral stenosis. Coronary angiography revealed severe ostial stenosis of the circumflex artery and a significant LAD/diagonal bifurcation lesion (Medina 0.1.1).
The operators performed balloon valvuloplasty to treat the mitral stenosis, followed by LAD/diagonal PCI....
Redefining standards: TAVI in the era of lifetime management, beyond high-risk patients
29 Sep 2025 – From PCR Gulf Valves 2025
Discover a selection of cases showcasing the key features of the Navitor Valve System and its clinical applications. This session explores auxiliary access, the use of Navitor in alternative access and complex PCI, its performance in challenging peripheral anatomies, and innovative outcomes with the Vantage 30D...
EuroPCR 2023 Welcome Ceremony
16 May 2023 – From EuroPCR 2023
As we celebrate the 30th anniversary of primary PCI for STEMI this year, follow the retrospective of this major advance in interventional cardiology, before listening to William Wijns, Jean Fajadet and their guests take stock of the current STEMI care worldwide at this opening ceremony which launches...
EuroPCR 2021 Hotlines / Late-Breaking Trials: TRILUMINATE, CLASP TR, bRIGHT, TRISCEND, TriBAND, and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in TRICUSPID:
- Percutaneous E2E repair for TR: 2-Year outcomes from the TRILUMINATE trial
- Transcatheter tricuspid valve repair: CLASP TR feasibility study 6-month results
- Clinical Response to Transcatheter treatment of tricuspid regurgitation: International TriValve registry
- Baseline characteristics and procedure outcomes from TriClip bRIGHT...
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
Imaging-guided PCI for stent failure - LIVE case
16 May 2024 – From EuroPCR 2024
An 86-year-old male with PAD, a stroke in 2007, and a history of LAD PCI in 2006, presented with unstable angina due to LAD stent restenosis involving D1 and D2, with preserved LV function.
Guided by OCT, the operators performed stenosis preparation using IVL, treated the distal...
Valve in valve in small degenerative surgical bioprosthesis - LIVE case
09 Feb 2025 – From PCR Tokyo Valves 2025
A 74-year-old female with a permanent pacemaker and preserved LV function presented with a symptomatic degenerative surgical valve (SJ Epic 21) implanted in 2016.
Patient underwent implantation of an Evolut FX 26 mm under general anesthesia with cerebral embolic protection and TEE guidance. A surgical valve fracture...
Outcomes after novel transcatheter and surgical tricuspid valve interventions
21 Nov 2021 – From PCR London Valves 2021
Find out more about TRI-SCORE, a new risk score to predict in-hospital mortality after isolated tricuspid valve surgery, 30-day outcomes for transcatheter tricuspid repair from the TriBAND study, both the CLASP TR early feasibility and TRISCEND studies six-month results, and more in this PCR London Valves...
QFR: the next-generation diagnostic tool for epicardial and microvascular disease in the cathlab
15 May 2024 – From EuroPCR 2024
Join this session to delve into the cutting-edge capabilities of the newest QFR technology, allowing for rapid coronary vessel analysis in under 30 seconds. Gain insight into the diagnostic potential of QFR-IMR for assessing coronary microvascular dysfunction and understand its implications for patient care. Explore the...
EuroPCR 2022 in words and images - What did we learn this year?
20 May 2022 – From EuroPCR 2022
Watch this video to get a brief look at the highlights of EuroPCR 2022 and learn about the:
- 30 years radial interview (Jean Fajadet)
- PCR's Got Talent winner interview
- Top 3 memories on coronary: ROBOTIC PCI, simulation-based learning on stent dislodgment and U-REDUCE STENT registry
- Top 3 publications EuroIntervention and...
EuroPCR 2022 Hotlines / Late-Breaking Trials in mitral and tricuspid: MITRA-TUNE, MitraBridge, TriCLASP, CLASP TR, and more!
19 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in mitral and tricuspid! MitraClip in atrial functional mitral regurgitation, two-year outcomes of MitraClip as a bridge to heart transplantation, TriCLASP post-market study, CLASP TR study one-year results, Cardioband TR early feasibility study, and initial 30-day results from...
Tailoring mitral repair and optimising clinical outcomes using MitraClip G4
27 Sep 2021 – From PCR Tokyo Valves 2021
Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...
